Business
Intelligent Bio Solutions Strengthens European IP Portfolio with Eighth Patent Grant
Patent strengthens competitive position in European drug screening market and reinforces Company's European intellectual property protection NEW YORK,
About this update from Intelligent Bio Solutions Inc.
[{"type":"text","content":"Patent strengthens competitive position in European drug screening market and reinforces Company's European intellectual property protection\nNEW YORK, March 26, 2026 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) (\"INBS\" or the \"Company\"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today announced it has received European Patent EP3752831, related to contextualizing fingerprint chemical analysis with fingerprint deposition volume. The grant marks the Company's eighth European patent, further enhancing intellectual property rights around its fingerprint sweat drug testing technology. The newly granted patent protects a key advancement in how the Company's technology analyzes substances detected in fingerprint sweat by correlating chemical findings with the volume of fingerprint residue deposited during sample collection. By contextualizing chemical analysis with deposition volume, the technology improves the interpretation of detected substances and strengthens the robustness of the testing process. This innovation adds another layer of sophistication to INBS' testing methodology. The Company's growing European IP portfolio now encompasses multiple aspects of its screening system, including lateral flow fingerprint analysis, sample collection cartridges, and lateral flow test strip reader. \"The grant of our eighth European patent reflects the depth of innovation embedded in our fingerprint sweat drug testing technology,\" said Harry Simeonidis, President and CEO at Intelligent Bio Solutions. \"Each patent we secure reinforces our market position and protects the scientific breakthroughs that make our non-invasive approach a compelling alternative to traditional drug screening methods.\" INBS' Intelligent Fingerprinting Drug Testing Solution offers organizations across safety-critical sectors a faster, more dignified alternative to conventional testing methods. By analyzing fingerprint sweat for the presence of common substances of abuse, the technology eliminates many of the logistical and privacy concerns associated with traditional sample collection while delivering rapid, reliable results. About Intelligent Bio Solutions Inc. Intelligent Bio Solutions Inc. (Nasdaq: INBS) is a medical technology company delivering intelligent, rapid, non-invasive tes...